Sex hormones and adaptive potential of the circulatory system in men of the European and Asian North

The article presents the results that reveal the features of the state of the hypothalamic-pituitary-gonadal axis and the level of dopamine in apparently healthy men with different adaptive potential of the circulatory system, taking into account age and territory of residence. Material and methods. The study involved 155 men (90 residents of the European North (Arkhangelsk Oblast) and 65 residents of the Asian North (Yamalo-Nenets Autonomous Okrug)) aged 22–59 years. Serum hormone levels of the hypothalamic-pituitary- gonadal axis were determined by enzyme immunoassay and radioimmunoassay in vitro analysis. The adaptive potential was calculated according to R.M. Baevsky. Results and its discussion. The functional tension of the mechanisms of adaptation of the circulatory system in men of the European North and unsatisfactory adaptation in men of the Asian North were revealed. In the studied regions of the North, there are no people with good and satisfactory adaptation, and the group of people with a breakdown in adaptation was identified only in the Asian North in men aged 45–59 years, which allows us to classify these subjects as a risk group for developing cardiovascular diseases. In men of the European North, the unsatisfactory adaptation was combined with an increase in the levels of prolactin (at the age of 22–44 years) and follitropin (at the age of 45–59 years) and a decrease in the level of sex hormone-binding globulin (at the age of 22–44 years). A decrease in the levels of total and free testosterone can be attributed to the key markers of failure of adaptation in men of the Asian North aged of 45–59 years. When analyzing the data of the entire surveyed population of men aged 22–59 years, an increase in aromatase activity was noted against the background of a decrease in testosterone levels in men of the European North with the 4th degree of adaptive potential and in men of the Asian North with the 5th degree of adaptive potential, which can be considered as a compensatory reaction to preserve the function of the cardiovascular system.

1. Baevskiy R.M., Berseneva A.P. Assessment of the body’s adaptive capabilities and the risk of disease development. Moscow: Meditsina, 1997. 236 p. [In Russian].

2. Regitz-Zagrosek V., Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol. Rev. 2017: 97 (1): 1–37. doi: 10.1152/physrev.00021.2015

3. Simonova O.I., Smetannikova O.V., Popova E.V., Ermakov N.A. Evaluation of functional indices and level of health of students in the period of their adaptation for studies in a college. Sibirskiy pedagogicheskiy zhurnal = Siberian Pedagogical Journal. 2017; (6): 154– 160. [In Russian]. doi: 10.15293/1813-4718.1805.15

4. Kolunin E.T., Prokopiev N.Ya., Gubin D.G., Durov A.M., Shevtsov A.V. Seasonal features of adaptive capacity in 8-year old boys at the initial stage of training speed and speed-power sports. Tyumenskiy meditsinskiy zhurnal = Tyumen Medical Journal. 2018; 20 (2): 15–17. [In Russian].

5. Pavlova V.I., Terzi M.S., Saraykin D.A. Physiological and physiological features of the sensorimotor adaptation in different qualifications combat sportsmen. Fundamental’nye issledovaniya = Fundamental Research. 2014; 6 (7): 1412–1417. [In Russian].

6. Churkin D.V., Gasendich E.S., Dolgoshapko O.N., Lastkov D.O. Assessment of the effectiveness of biologically active additives complex in the adaptation of the military after pneumonia. Meditsina v Kuzbasse = Medicine in Kuzbass. 2016; 15 (4): 9–13. [In Russian].

7. Gorenko I.N., Kipriyanova K.E., Tipisova E.V. Adaptive potential and its correlation with sex hormones and dopamine in men from Nes village (Nenets Autonomous Area). Zhurnal mediko-biologicheskikh issledovaniy = Journal of Medical and Biological Research. 2018; 6 (2): 105–114. [In Russian]. doi: 10.17238/issn2542-1298.2018.6.2.105

8. Molodovskaya I.N. Functional state of the hypothalamuspituitary-gonad axis in healthy men with various adaptation potential. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics. 2021; 66 (1): 10–14. [In Russian]. doi: 10.18821/0869-2084-2021-66-1-10-14

9. Gao Z., Chen Z., Sun A., Deng X. Gender differences in cardiovascular disease. Med. Nov. Technol. Devices. 2019; 4: 1000252. doi: 10.1016/j.medntd.2019.100025

10. Cooke P.S., Nanjappa M.K., Ko C., Prins G.S., Hess R.A. Estrogens in male physiology. Physiol. Rev. 2017; 97: 995–1043. doi: 10.1152/physrev.00018.2016

11. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K.S., Simpson E.R. Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 1997; 337: 91–95. doi: 10.1056/NEJM199707103370204

12. Vikan T., Schirmer H., Njolstad I., Svartberg J. Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur. J. Endocrinol. 2010; 162: 747–754. doi: 10.1530/EJE-09-0943

13. Sudhir K., Chou T.M., Messina L.M., Hutchison S.J., Korach K.S., Chatterjee K., Rubanyi G.M. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet. 1997; 349 (9059): 1146–1147. doi: 10.1016/S0140-6736(05)63022-X

14. Jankowska E.A., Rozentryt P., Ponikowska B., Hartmann O., Kustrzycka-Kratochwil D., Reczuch K., Nowak J., Borodulin-Nadzieja L., Polonski L., BanasiakW., Poole-Wilson P.A., Anker S.D., Ponikowski P. Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA. 2009; 301 (18): 1892– 1901. doi: 10.1001/jama.2009.639

15. Yeap B.B. Androgens and cardiovascular disease. Curr. Opin. Endocrinol. Diabetes Obes. 2010; 17 (3): 269–276. doi: 10.1097/MED.0b013e3283383031

16. Tirabassi G., Gioia A., Giovannini L., Boskaro M., Corona G., Carpi A., Maggi M., Balercia G. Testosterone and cardiovascular risk. Inter. Emerg. Med. 2013; 8 (1): 65–69. doi: 10.1007/s11739-013-0914-1

17. Crawford D., Schally A.V., Pinthus J.H., Block N.L., Rick F.G., Garnick M.B., Eckel R.H., Keane T.E., Shore N.D., Dahdal D.N., Beveridge T.J.R., Marshall D.C. The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy. Urol. Oncol. 2017; 35 (5): 183–191. doi: 10.1016/j.urolonc.2017.01.025

18. Pugeat M., Moulin P., Cousin P., Fimbel S., Nicolas M.H., Crave J.C., Lejeune H. Interrelations between sex hormone-binding globulin (SHBG), plasma lipoproteins and cardiovascular risk. J. Steroid Biochem. Mol. Biol. 1995; 53 (1-6): 567–572. doi: 10.1016/0960-0760(95)00102-6

19. Cosentino M., Kustrimovic N., Marino F. Endogenous catecholamines in immune cells: Discovery, functions and clinical potential as therapeutic targets [Electronic resource]. Brain Immune: Trends in Neuroendocrine Immunology. 2013. Available at: http://www.brainimmune.com/endogenous-catecholamines-in-immune-cells-discovery-functions-and-clinical-potential-as-pharmacotherapeutic-targets-3/

20. McGrath B.P., Wang X.Q. Dopamine: clinical applications iii. cardiovascular. Aust. Prescriber. 1994; 17 (2): 44–45. doi: 10.18773/austprescr.1994.050

21. Sevostyanova Y.V. Some features of human lipid and carbohydrate metabolism in the North. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2013; 12 (1). 93–100. [In Russian]. doi: 10.20538/1682-0363-2013-1-

22. Chu C., Xu B., Huang W. A study on expression of FSH and its effects on the secretion of insulin and glucagon in rat pancreas. Tissue Cell. 2010; 42: 370– 375. doi: 10.1016/j.tice.2010.09.001

23. Ulloa-Aguirre A., Zarinan T. The Follitropin receptor: Matching structure and function. Mol. Pharmacol. 2016; 90: 596–608. doi: 10.1124/mol.116.104398

24. Gyawali P., Martin S.A., Heilbronn L.K., Vincent A.D., Jenkins A.J., Januszewski A.S., Adams R.G.T., O’Loughlin P.D., Wittert G.A. Higher serum sex hormone-binding globulin levels are associated with incident cardiovascular disease in men. J. Clin. Endocrinol. Metab. 2019; 104 (12): 6301–6315. doi: 10.1210/jc.2019-01317

25. Herring M.J., Oskui P.M., Hale S.L., Kloner R.A. Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J. Am. Heart Assoc. 2013; 2 (4): e000271. doi: 10.1161/JAHA.113.000271

26. Subbiah M.T.R. Estrogen replacement therapy and cardioprotection: mechanisms and controversies. Braz. J. Med. Biol. Res. 2002; 35 (3): 271–276. doi: 10.1590/S0100-879X2002000300001

27. Shalaby A., Eliwa K.A.A., Hassan A.M., ElFiky M. Sex differences in some physiological effects of cold season or short-term cold exposure in adult albino rat. Endocrinol. Metab. Synd. 2015; 4 (1): 159–165. doi: 10.4172/2161-1017.1000159

28. Xing L., Esau C., Trudeau V.L. Direct regulation of aromatase B expression by 17β-estradiol and dopamine D1 receptor agonist in adult radial glial cells. Front. Neurosci. 2016; 9: 504. doi: 10.3389/fnins.2015.00504